Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
Prestige Consumer Healthcare (NYSE:PBH) announced its participation in the upcoming Barclays Global Consumer Staples Conference. The presentation is scheduled for Thursday, September 4, 2025 at 12:45 p.m. ET.
Investors and interested parties can access the live webcast through the company's website under the "Investors" section and "Events and Presentations" tab. A replay of the presentation will be made available on the company's website after the event.
Prestige Consumer Healthcare (NYSE:PBH) parteciperà alla prossima Barclays Global Consumer Staples Conference. La presentazione è programmata per giovedì 4 settembre 2025 alle 12:45 p.m. ET.
Investitori e interessati potranno seguire la diretta streaming tramite il sito web della società, nella sezione "Investors" alla voce "Events and Presentations". Una registrazione della presentazione sarà disponibile sul sito web aziendale dopo l'evento.
Prestige Consumer Healthcare (NYSE:PBH) anunció su participación en la próxima Barclays Global Consumer Staples Conference. La presentación tendrá lugar el jueves 4 de septiembre de 2025 a las 12:45 p.m. ET.
Los inversores y demás interesados podrán acceder a la retransmisión en directo a través del sitio web de la compañía, en la sección "Investors" y la pestaña "Events and Presentations". La presentación quedará disponible en replay en la web de la empresa tras el evento.
Prestige Consumer Healthcare (NYSE:PBH)가 다가오는 Barclays Global Consumer Staples Conference에 참가한다고 발표했습니다. 발표는 2025년 9월 4일 목요일 동부시간 오후 12시 45분에 예정되어 있습니다.
투자자 및 관심 있는 분들은 회사 웹사이트의 "Investors" 섹션 내 "Events and Presentations" 탭을 통해 라이브 웹캐스트를 시청할 수 있습니다. 발표 녹화본은 행사 후 회사 웹사이트에 게시될 예정입니다.
Prestige Consumer Healthcare (NYSE:PBH) a annoncé sa participation à la prochaine Barclays Global Consumer Staples Conference. La présentation est prévue le jeudi 4 septembre 2025 à 12h45 (ET).
Les investisseurs et personnes intéressées pourront suivre la webdiffusion en direct depuis le site internet de la société, dans la rubrique "Investors" puis l'onglet "Events and Presentations". Un enregistrement de la présentation sera mis en ligne sur le site après l'événement.
Prestige Consumer Healthcare (NYSE:PBH) gab bekannt, dass das Unternehmen an der kommenden Barclays Global Consumer Staples Conference teilnimmt. Die Präsentation ist für Donnerstag, den 4. September 2025 um 12:45 Uhr ET angesetzt.
Investoren und Interessenten können den Live-Webcast über die Unternehmenswebsite unter der Rubrik "Investors" und dem Reiter "Events and Presentations" verfolgen. Eine Aufzeichnung der Präsentation wird nach der Veranstaltung auf der Website verfügbar sein.
- None.
- None.
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 4, 2025 at 12:45 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the “Investors” section and the “Events and Presentations” tab, or by using the following link:
https://ir.prestigebrands.com/events-presentations/events
For those unable to participate during the live webcast, a replay option will be available on the Company’s website following the event.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is a leading consumer healthcare products company with sales throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com
